Eversept Partners, LP
Top Portfolio Positions
110 positions ·
$1,817,420,308 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
264,271 | $156,707,417 | 8.62% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
238,700 | $137,772,866 | 7.58% | |
| ABVX |
Abivax S.A.
Healthcare
|
934,423 | $104,048,001 | 5.73% | |
| GSK |
GSK plc
Healthcare
|
1,785,175 | $98,523,808 | 5.42% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
2,173,286 | $87,431,295 | 4.81% | |
| NTRA |
Natera, Inc.
Healthcare
|
384,713 | $76,938,752 | 4.23% | |
| SPY |
Spdr S&P 500 ETF Trust
|
107,000 | $69,586,380 | 3.83% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
2,885,622 | $67,408,129 | 3.71% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
1,788,016 | $56,715,867 | 3.12% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
924,193 | $53,704,855 | 2.96% |
Portfolio Trend
25 quarters · across all stocks
Holdings in CLDX
Shares Held
Position Value (USD)
20 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $56,715,867 | 1,788,016 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,967,131 | 1,434,725 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,851,910 | 1,153,920 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,068,277 | 838,736 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,641,456 | 696,499 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,190,255 | 719,836 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,201,018 | 564,902 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,427,885 | 633,015 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $29,845,496 | 711,115 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $29,907,883 | 754,107 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,185,695 | 588,143 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,660,158 | 785,740 | Shares | Sole | 2023-11-08 | |
| 2023-03-31 | $24,814,542 | 689,676 | Shares | Sole | 2023-11-08 | |
| 2022-12-31 | $24,904,557 | 558,774 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $17,607,316 | 626,372 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,892,380 | 552,388 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $21,677,589 | 636,453 | Shares | Sole | 2023-11-08 | |
| 2021-12-31 | $22,893,349 | 592,478 | Shares | Sole | 2022-02-14 | |
| 2020-09-30 | $2,231,826 | 150,494 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $9,265,074 | 712,698 | Shares | Sole | 2023-11-08 | |
| No 13F history on record for this holder in this stock. | ||||||